Filing Details
- Accession Number:
- 0001209191-20-020125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-18 20:20:58
- Reporting Period:
- 2020-03-16
- Accepted Time:
- 2020-03-18 20:20:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636050 | Axovant Gene Therapies Ltd. | AXGT | Pharmaceutical Preparations (2834) | 981333697 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643071 | Atul Pande | C/O Axovant Gene Therapies Ltd. 11 Times Square, 33Rd Floor New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-16 | 10,000 | $1.78 | 13,370 | No | 4 | P | Indirect | By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Atul C. Pande & Patricia A Pande TR DTD 08/24/2017 |
Footnotes
- The reported price in Column 4 is a weighted-average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.77 to $1.82 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- Includes 3,370 shares that were previously reported as directly owned.
Billionaire Hedge Funds
